SOTERA HEALTH COMPANY Unrealized Gain (Loss) on Cash Flow Hedging Instruments
SOTERA HEALTH COMPANY (SHC) reported Unrealized Gain (Loss) on Cash Flow Hedging Instruments of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments · last filed 2021-05-13
- SOTERA HEALTH COMPANY unrealized gain (loss) on cash flow hedging instruments for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY unrealized gain (loss) on cash flow hedging instruments for the quarter ending 2020-03-31 was $4.71M.
| Period end | Unrealized Gain (Loss) on Cash Flow Hedging Instruments 3 month |
|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 |
| 2020-03-31 | $4.71M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |